Back
CRISPR Therapeutics AG Stock Price Chart
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!
Sell
6
CRSP
CRISPR Therapeutics AG
Last Price:
$39.88
Seasonality Move:
13.67%
7 Day Trial
ALL ACCESS PASS
$
7
Free Report: 7 Nuclear Stocks Set to Rise
Grab your copy now!-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.72 | Sell |
| 20-day SMA: | 42.82 | Sell |
| 50-day SMA: | 42.77 | Sell |
| 200-day SMA: | 48.27 | Sell |
| 8-day EMA: | 26.3 | Buy |
| 20-day EMA: | 13.68 | Buy |
| 50-day EMA: | 6.13 | Buy |
| 200-day EMA: | 1.63 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.23 | Buy |
| Relative Strength Index (14 RSI): | 43.54 | Sell |
| Chaikin Money Flow: | -1431436 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.96 - 47.82) | Sell |
| Bollinger Bands (100): | (40.53 - 49.17) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.89 while CRSP 8-day simple moving average is 41.72, which is a Sell signal.
-
The stock price of CRSP is 40.89 while CRISPR Therapeutics AG 20-day SMA is 42.82, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 42.77 while CRSP share price is 40.89, making it a Sell technically.
-
CRSP stock price is 40.89 and CRISPR Therapeutics AG 200-day simple moving average is 48.27, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
6
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $40.89. The Score for CRSP is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.5B
Price in USD:
40.89
Share Volume:
1.6M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
73.09
52-Week Low:
36.52
Sell
6
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 40.89 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.89 while CRSP 8-day exponential moving average is 26.30, which is a Buy signal.
-
The stock price of CRSP is 40.89 while CRISPR Therapeutics AG 20-day EMA is 13.68, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 6.13 while CRSP share price is 40.89, making it a Buy technically.
-
CRSP stock price is 40.89 and CRISPR Therapeutics AG 200-day simple moving average is 1.63, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 9.23, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 43.54, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (40.96 - 47.82), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (40.53 - 49.17), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.